BIOTECHNOLOGY VALUE FUND L P - 31 Dec 2024 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
VTGN
Shares outstanding
30,936,048 shares
Disclosed Ownership
3,084,324 shares
Ownership
9.97%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:28:38 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.4% 1,589,495 0 1,589,495 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.4% 1,589,495 0 1,589,495 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.4% 1,289,734 0 1,289,734 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.4% 1,289,734 0 1,289,734 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.6% 158,606 0 158,606 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.6% 158,606 0 158,606 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 2,879,229 0 2,879,229 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.97% 3,084,324 0 3,084,324 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.97% 3,084,324 0 3,084,324 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.97% 3,084,324 0 3,084,324 /s/ Mark N. Lampert Mark N. Lampert